EUDA Health Holdings Warrant
EUDAW
9 hedge funds and large institutions have $120K invested in EUDA Health Holdings Warrant in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.34% less ownership
Funds ownership: 4.39% → 4.05% (-0.34%)
15% less capital invested
Capital invested by funds: $141K → $120K (-$21.9K)
25% less funds holding
Funds holding: 12 → 9 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$6.77K |
| 2 |
VF
Virtu Financial
New York
|
-$2K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$603 |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$327 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13 |
EUDAW Hedge Fund Activity: Q1 2025 in Review
9 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q1 2025, worth a combined $120K — down 15% from $141K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EUDAW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $6.77K sold.
- 9 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q1 2025, down from 12 in Q4 2024.
- Funds reported $120K of EUDA Health Holdings Warrant stock for Q1 2025, down 15% quarter-over-quarter.
- 0 funds opened new EUDA Health Holdings Warrant positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest EUDA Health Holdings Warrant seller in Q1 2025 was Hudson Bay Capital Management, an estimated $6.77K sold.
Based on aggregated 13F filings for Q1 2025.